Literature DB >> 4737325

The preparation of activated factor X and its action on prothrombin.

J Jesty, M P Esnouf.   

Abstract

The preparation of activated Factor X from reaction mixtures of bovine Factor X and Russell's-viper venom is described. The molecular weight of purified protein varies about a mean value of 40000; this variation is the result of at least two forms of Factor Xa. The action of activated Factor X, together with purified Factor V, was studied on purified prothrombin and the reaction products were isolated. In addition to thrombin, two other polypeptides with molecular weights of 16000 and 19500 were recovered.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4737325      PMCID: PMC1177539          DOI: 10.1042/bj1310791

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.

Authors:  D PAPAHADJOPOULOS; D J HANAHAN
Journal:  Biochim Biophys Acta       Date:  1964-08-19

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  A spectrophotometric determination of trypsin and chymotrypsin.

Authors:  G W SCHWERT; Y TAKENAKA
Journal:  Biochim Biophys Acta       Date:  1955-04

4.  Purification and some properties of autoprothrombin C.

Authors:  W H SEEGERS; E R COLE; C R HARMISON; E MARCINIAK
Journal:  Can J Biochem Physiol       Date:  1963-04

5.  The specific assay of Prower-Stuart factor and factor VII.

Authors:  K W DENSON
Journal:  Acta Haematol       Date:  1961-02       Impact factor: 2.195

6.  The isolation of factor V from bovine plasma.

Authors:  M P Esnouf; F Jobin
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

7.  Multiple active forms of thrombin. I. Partial resolution, differential activities, and sequential formation.

Authors:  K G Mann; C M Heldebrant; D N Fass
Journal:  J Biol Chem       Date:  1971-10-10       Impact factor: 5.157

8.  Two forms of the human prothrombin converting enzyme (active factor X).

Authors:  D L Aronson; A J Mustafa; J S Finlayson
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

9.  The conversion of prethrombin to thrombin.

Authors:  W J Baker; W H Seegers
Journal:  Thromb Diath Haemorrh       Date:  1967-02-28

10.  Studies on the formation of the prothrombin-converting complex.

Authors:  F Jobin; M P Esnouf
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

View more
  7 in total

1.  Role of proteolytic enzymes in biological regulation (a review).

Authors:  H Neurath; K A Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

2.  Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.

Authors:  A K Sinha; A K Rao; J Willis; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

3.  Rapid purification of high purity thrombin and preparation of a novel hemostat for clinical purposes.

Authors:  Krishna Kumar Turaga; P Chakradhara Rao; G Sripad
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

4.  Insight from TonB hybrid proteins into the mechanism of iron transport through the outer membrane.

Authors:  Wallace A Kaserer; Xiaoxu Jiang; Qiaobin Xiao; Daniel C Scott; Matthew Bauler; Daniel Copeland; Salete M C Newton; Phillip E Klebba
Journal:  J Bacteriol       Date:  2008-04-04       Impact factor: 3.490

5.  Activation of bovine factor X (Stuart factor): conversion of factor Xaalpha to factor Xabeta.

Authors:  K Fujikawa; K Titani; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

6.  Pathways in the activation of human coagulation factor X.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

7.  Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).

Authors:  Michael Dockal; Rudolf Hartmann; Markus Fries; M Christella L G D Thomassen; Alexandra Heinzmann; Hartmut Ehrlich; Jan Rosing; Frank Osterkamp; Thomas Polakowski; Ulrich Reineke; Andreas Griessner; Hans Brandstetter; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.